Clinical Trials Logo
  1. Home
  2. Cataract
  3. NCT05288192
  4. Details
NCT05288192 Clinical Trial

Changes After Suprachoroidal Injection.

Cataract Clinical Trial

Official title:
Changes Noted After Suprachoroidal Triamcinolone Acetonide Injection.

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05288192
Other study ID # Rc-3-22
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 15, 2022
Est. completion date September 1, 2022

Study information
Verified date March 2022
Source Benha University
Contact Ahmed Abdelshafy
Phone 01222328766
Email ahmad4lg@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Changes after suprachoroidal injection are analyzed for statistical analysis.

Description:

Changes after suprachoroidal injection of triamcinolone acetonide are noted in various retinal diseases treated by this technique to address its effects over six months of follow-up.

Recruitment information / eligibility
Status Recruiting
Enrollment 30
Est. completion date September 1, 2022
Est. primary completion date August 30, 2022
Accepts healthy volunteers No
Gender All
Age group 30 Years to 80 Years
Eligibility Inclusion Criteria: - Patients prepared to suprachoroidal injection for various retinal diseases will be enrolled in the study. - Bilateral retinal diseases that required interventions as diabetic macular edema, exudative retinal detachment, and serous chorioretinopathies. Exclusion Criteria: - Other retinal diseases that are not expected to improve after steroid injections as central retinal artery occlusion and age-related macular degenerations. - Choroidal neovascularization that require anti-vascular endothelial growth factors. - Patients refused to have steroid injections even after discussing the nature of their disease with them and the procedure to be done.

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Suprachoroidal triamcinolone acetonide (SCTA) injection
Suprachoroidal injection of 4mg/0.1ml of triamcinolone acetonide.

Locations
Country Name City State
Egypt Benha University Banha QA

Sponsors (1)
Lead Sponsor Collaborator
Benha University

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary Changes in visual acuity Changes in best corrected visual acuity after injection Monthly after injection till six months of follow up
Primary Changes in central foveal thickness Changes in central macular thickness after injection Monthly after injection till six months of follow up
Secondary Changes in intraocular pressure Changes in intraocular pressure after injection Monthly after injection till six months of follow up
Secondary Changes in lens Cataract progression after injection Monthly after injection till six months of follow up
See also
  Status Clinical Trial Phase
Completed NCT04685538 - Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification. Phase 3
Recruiting NCT06060041 - IC-8 Apthera IOL New Enrollment Post Approval Study
Recruiting NCT05518539 - Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
Recruiting NCT05271942 - Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods N/A
Active, not recruiting NCT04778501 - PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia N/A
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT03751033 - Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings N/A
Completed NCT02529488 - Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00 N/A
Completed NCT04539548 - A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract Phase 3
Completed NCT03740659 - Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery Phase 2
Completed NCT03494257 - Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification N/A
Completed NCT05119127 - Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome. N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03713268 - Intraoperative OCT Guidance of Intraocular Surgery II
Completed NCT03739528 - Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery Phase 3
Completed NCT02888210 - A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery Phase 3
Completed NCT03356847 - Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery N/A
Completed NCT04332640 - Clinical Evaluation of the Next Generation Phaco System N/A
Recruiting NCT03638726 - Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification Phase 4
Completed NCT03050697 - Evaluation of the Safety and Performance of the HARMONI® Toric Lens N/A